Analysts Offer Insights on Healthcare Companies: ICAD (ICAD), Mustang Bio (MBIO) and Cerus (CERS)
Cerus Analyst Ratings
Cerus Corporation's New Share Price & Shareholder Rights Risk – A Cause for Worry?
Cerus Analyst Ratings
Stifel Nicolaus Keeps Their Buy Rating on Cerus (CERS)
Cerus (CERS) Receives a Hold From BTIG
Cerus (CERS) Receives a Hold From BTIG
BTIG Remains a Hold on Cerus (CERS)
Cantor Fitzgerald Assumes Cerus at Overweight, Lowers Price Target of $3
Cerus Analyst Ratings
BTIG Sticks to Its Hold Rating for Cerus (CERS)
BTIG Keeps Their Hold Rating on Cerus (CERS)
Cerus Analyst Ratings
BTIG Sticks to Its Buy Rating for Cerus (CERS)
No Data